Evidence map›Paper›PMID 28939861›Full record

ArticleScientific reports2017

Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane.

Jeffrey L Werbin, Maier S Avendaño, Verena Becker, Ralf Jungmann, Peng Yin, Gaudenz Danuser, Peter K Sorger

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Small Fluorogenic Amino Acids for Peptide-Guided Background-Free Imaging.Angewandte Chemie (International ed. in English) · 2023
    Article
  8. Small Fluorogenic Amino Acids for Peptide-Guided Background-Free Imaging.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Profiling Cell Signaling Networks at Single-cell Resolution.Molecular & cellular proteomics : MCP · 2020
    Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jeffrey L WerbinHMS LINCS Center, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
Maier S AvendañoDepartment of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA.
Verena BeckerHMS LINCS Center, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
Ralf JungmannDepartment of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA.
Peng YinDepartment of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA. Peng_Yin@hms.harvard.edu.
Gaudenz DanuserDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA. Gaudenz.Danuser@utsouthwestern.edu.
Peter K SorgerHMS LINCS Center, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, 02115, USA. peter_sorger@hms.harvard.edu.
Harvard University · USCenter for Systems Biology · USMax Planck Institute of Biochemistry · DE

Funding

Tumor Cell Networks CenterU54CA112967 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LAUFFENBURGER, DOUGLAS A · 2004 to 2015
$26.2M
Pharmaco Response Signatures and Disease MechanismU54HL127365 · NHLBI · HARVARD MEDICAL SCHOOL · PI SORGER, PETER KARL · 2014 to 2019
$13.1M
Super-resolution imaging via programmable autonomous blinkingR01EB018659 · NIBIB · HARVARD MEDICAL SCHOOL · PI YIN, PENG · 2013 to 2017
$3.3M
Engineering Bioimaging Probes Based on Triggered Molecular GeometryDP2OD007292 · OD · HARVARD MEDICAL SCHOOL · PI YIN, PENG · 2010 to 2010
$2.5M
Quantitative Fluorescent Speckle MicroscopyU01GM067230 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI DANUSER, GAUDENZ · 2008 to 2011
$1.7M
Programmable metafluorophores for quantitative multiplex in situ imaging of mRNAR21HD072481 · NICHD · HARVARD MEDICAL SCHOOL · PI YIN, PENG · 2012 to 2013
$452k
Howard Hughes Medical InstituteNCI NIH HHS U54 CA112967NHLBI NIH HHS U54 HL127365NIBIB NIH HHS R01 EB018659NICHD NIH HHS R21 HD072481NIGMS NIH HHS U01 GM067230NIH HHS DP2 OD007292
6 · The paper itself

Abstract

Signal transduction by receptor tyrosine kinases (RTKs) involves complex ligand- and time-dependent changes in conformation and modification state. High resolution structures are available for individual receptors dimers, but less is known about receptor clusters that form in plasma membranes composed of many different RTKs with the potential to interact. We report the use of multiplexed super-resolution imaging (Exchange-PAINT) followed by mean-shift clustering and random forest analysis to measure the precise distributions of five receptor tyrosine kinases (RTKs) from the ErbB, IGF-1R and Met families in breast cancer cells. We find that these receptors are intermixed nonhomogenously on the plasma membrane. Stimulation by EGF does not appear to induce a change in the density of EGFR in local clusters but instead results in formation of EGFR-Met and EGFR-ErbB3 associations; non-canonical EGFR-Met interactions are implicated in resistance to anti-cancer drugs but have not been previously detected in drug-naïve cells.

Indexed as

Protein Interaction MapsAnimalsCell LineCell MembraneCHO CellsCluster AnalysisCricetulusEpidermal Growth FactorErbB ReceptorsHumansMachine LearningOptical ImagingProtein Interaction MappingProto-Oncogene Proteins c-metReceptor, ErbB-3EGFR protein, humanEpidermal Growth FactorErbB ReceptorsMET protein, humanProto-Oncogene Proteins c-metReceptor, ErbB-3

Identifiers

PMID28939861
PMCPMC5610318
OpenAlexW2756343412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.